These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6800678)

  • 1. On the kinetics and dynamics of tocainide and its metabolites.
    Ronfeld RA; Wolshin EM; Block AJ
    Clin Pharmacol Ther; 1982 Mar; 31(3):384-92. PubMed ID: 6800678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocainide. A review of its pharmacological properties and therapeutic efficacy.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocainide: a new oral antiarrhythmic agent.
    Kutalek SP; Morganroth J; Horowitz LN
    Ann Intern Med; 1985 Sep; 103(3):387-91. PubMed ID: 3927807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine.
    Alpert JS; Haffajee CI; Young MD
    Pharmacotherapy; 1983; 3(6):316-23. PubMed ID: 6419205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.
    Wallace AA; Stupienski RF; Heaney LA; Gehret JR; Lynch JJ
    Am Heart J; 1991 May; 121(5):1413-21. PubMed ID: 1708198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
    MacMahon B; Bakshi M; Branagan P; Kelly JG; Walsh MJ
    Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarction.
    Rehnqvist N; Erhardt L; Ericsson CG; Olsson G; Svensson G; Sjögren A
    Acta Med Scand; 1983; 214(1):21-7. PubMed ID: 6414252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of tocainide in the rat.
    Venkataramanan R; Abbott FS; Axelson JE
    J Pharm Sci; 1982 May; 71(5):491-4. PubMed ID: 6808112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent.
    Morganroth J; Nestico PF; Horowitz LN
    Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocainide: a new drug for ventricular arrhythmias.
    Volosin KJ; Greenspon AJ
    Am Fam Physician; 1986 Jan; 33(1):233-5. PubMed ID: 3079938
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective effects of tocainide in canine acute myocardial infarction.
    Hiromasa S; Li ZY; Coto H; Maldonado C; Kupersmith J
    Int J Cardiol; 1990 Apr; 27(1):79-86. PubMed ID: 2110552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocainide for arrhythmias.
    Med Lett Drugs Ther; 1985 Feb; 27(680):9-11. PubMed ID: 3918240
    [No Abstract]   [Full Text] [Related]  

  • 14. Tocainide.
    Hanyok JJ
    Conn Med; 1985 Dec; 49(12):827-8. PubMed ID: 3936674
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis of primary ventricular fibrillation with tocainide in acute myocardial infarction.
    Campbell RW; Hutton I; Elton RA; Goodfellow RM; Taylor E
    Br Heart J; 1983 Jun; 49(6):557-63. PubMed ID: 6405764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocainide and mexiletine. Orally effective lidocaine analogues.
    Roden DM
    Arch Intern Med; 1985 Mar; 145(3):417-8. PubMed ID: 3919665
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
    Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocainide and mortality after myocardial infarction: a prospective study in conscious dogs.
    Vanoli E; Hull SS; Stith RD; Adamson PB; Foreman RD; Schwartz PJ
    J Am Coll Cardiol; 1990 Nov; 16(6):1475-80. PubMed ID: 2121814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselectivity of tocainide pharmacodynamics in vivo and in vitro.
    Block AJ; Merrill D; Smith ER
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):216-21. PubMed ID: 2452317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.